Replimune
REPL
#4939
Rank
A$2.73 B
Marketcap
A$28.81
Share price
-0.83%
Change (1 day)
102.25%
Change (1 year)

Earnings for Replimune (REPL)

Earnings in 2026 (TTM): -A$0.38 Billion

According to Replimune 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.47 Billion a decrease over its 2024 earnings that were of -A$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Replimune from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.38 Billion-18.21%
2025 -A$0.47 Billion39.76%
2024 -A$0.34 Billion8.36%
2023 -A$0.31 Billion32.11%
2022 -A$0.24 Billion45.44%
2021 -A$0.16 Billion47.15%
2020 -A$0.11 Billion66.74%
2019 -A$65.03 Million65.45%
2018 -A$39.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion-40.09%๐Ÿ‡บ๐Ÿ‡ธ USA